Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox injection in rectus femoris for stiff knee gait after stroke
2009-018226-29Phase 3Active
- Start
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of botulinum toxin type A in stroke and Gait disorder. Primary endpoint: Knee range of motion during swing phase. Started Jan 2010; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
strokeGait disorder
Beyond the preview
Go deeper on 2009-018226-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018226-29.